Flint Development wins Spotsylvania County approval for Patriot 95 logistics facility in Thornburg, VA
Read More 5 minute read Pharma Industry News Can ifinatamab deruxtecan redefine treatment for late-stage small cell lung cancer? Here’s what the trial shows Discover how ifinatamab deruxtecan delivered a 48% objective response rate in pretreated ES-SCLC. Read on for trial results and next steps. byPallavi MadhirajuSeptember 7, 2025